1. Home
  2. ONCO vs ORIS Comparison

ONCO vs ORIS Comparison

Compare ONCO & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Onconetix Inc.

ONCO

Onconetix Inc.

HOLD

Current Price

$1.65

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

ORIS

Oriental Rise Holdings Limited Ordinary Shares

HOLD

Current Price

$1.33

Market Cap

3.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONCO
ORIS
Founded
2018
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
3.7M
IPO Year
2022
2024

Fundamental Metrics

Financial Performance
Metric
ONCO
ORIS
Price
$1.65
$1.33
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
55.1K
532.2K
Earning Date
11-13-2025
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
$1,223,751.00
$12,317,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$181.14
Revenue Growth
N/A
N/A
52 Week Low
$1.37
$1.11
52 Week High
$88.40
$57.00

Technical Indicators

Market Signals
Indicator
ONCO
ORIS
Relative Strength Index (RSI) 37.01 85.15
Support Level $1.37 $1.11
Resistance Level $1.71 $1.76
Average True Range (ATR) 0.18 0.08
MACD 0.00 0.15
Stochastic Oscillator 28.00 75.16

Price Performance

Historical Comparison
ONCO
ORIS

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).

Share on Social Networks: